157 related articles for article (PubMed ID: 35689719)
21. Circumferential distribution and clinical characteristics of esophageal cancer in lower esophagus: differences related to histological subtype.
Okada M; Ishimura N; Mikami H; Okimoto E; Oshima N; Miyaoka Y; Fujishiro H; Ishihara S; Kinoshita Y
Esophagus; 2019 Jan; 16(1):98-106. PubMed ID: 30145681
[TBL] [Abstract][Full Text] [Related]
22. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.
Morgan E; Soerjomataram I; Rumgay H; Coleman HG; Thrift AP; Vignat J; Laversanne M; Ferlay J; Arnold M
Gastroenterology; 2022 Sep; 163(3):649-658.e2. PubMed ID: 35671803
[TBL] [Abstract][Full Text] [Related]
23. Gene Expression in Barrett's Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma.
Panda A; Bhanot G; Ganesan S; Bajpai M
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885081
[TBL] [Abstract][Full Text] [Related]
24. Investigating Trends of Incidence Rates of Esophageal Cancer Divided by Squamous Cell Carcinoma and Adenocarcinoma in Southern Iran: a 10-Year Experience.
Hosseini-Bensenjan M; Vardanjani HM; Haghpanah S; Khosravizadegan Z; Bagheri-Lankarani K
J Gastrointest Cancer; 2022 Mar; 53(1):230-234. PubMed ID: 34855123
[TBL] [Abstract][Full Text] [Related]
25. Disparities in esophageal cancer incidence and esophageal adenocarcinoma mortality in the United States over the last 25-40 years.
Arshad HMS; Farooq U; Cheema A; Arshad A; Masood M; Vega KJ
World J Gastrointest Endosc; 2023 Dec; 15(12):715-724. PubMed ID: 38187915
[TBL] [Abstract][Full Text] [Related]
26. Global trends in esophageal cancer mortality with predictions to 2025, and in incidence by histotype.
Santucci C; Mignozzi S; Malvezzi M; Collatuzzo G; Levi F; La Vecchia C; Negri E
Cancer Epidemiol; 2023 Dec; 87():102486. PubMed ID: 37956470
[TBL] [Abstract][Full Text] [Related]
27. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
28. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.
Lindkvist B; Johansen D; Stocks T; Concin H; Bjørge T; Almquist M; Häggström C; Engeland A; Hallmans G; Nagel G; Jonsson H; Selmer R; Ulmer H; Tretli S; Stattin P; Manjer J
BMC Cancer; 2014 Feb; 14():103. PubMed ID: 24548688
[TBL] [Abstract][Full Text] [Related]
29. Changing trends in cancer incidence of upper aerodigestive tract and stomach in Japanese alcohol-dependent men (1993-2018).
Yokoyama A; Omori T; Yokoyama T
Cancer Med; 2020 Jan; 9(2):837-846. PubMed ID: 31957322
[TBL] [Abstract][Full Text] [Related]
30. Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries.
Huang J; Koulaouzidis A; Marlicz W; Lok V; Chu C; Ngai CH; Zhang L; Chen P; Wang S; Yuan J; Lao XQ; Tse SLA; Xu W; Zheng ZJ; Xie SH; Wong MCS
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33466239
[TBL] [Abstract][Full Text] [Related]
31. Descriptive epidemiology of esophageal carcinoma in the Ohio Cancer Registry.
Cummings LC; Cooper GS
Cancer Detect Prev; 2008; 32(1):87-92. PubMed ID: 18406068
[TBL] [Abstract][Full Text] [Related]
32. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
[TBL] [Abstract][Full Text] [Related]
33. Incidence trends of esophageal cancer in the Czech Republic by histological subtype and stage and prescription rate of acid suppressing drugs.
Kroupa R; Katinova I; Pavlik T; Kunovsky L; Prochazka V; Borilova Linhartova P; Packova B; Kala Z; Dolina J
Cancer Epidemiol; 2020 Dec; 69():101853. PubMed ID: 33161372
[TBL] [Abstract][Full Text] [Related]
34. Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysis.
Singh S; Manickam P; Amin AV; Samala N; Schouten LJ; Iyer PG; Desai TK
Gastrointest Endosc; 2014 Jun; 79(6):897-909.e4; quiz 983.e1, 983.e3. PubMed ID: 24556051
[TBL] [Abstract][Full Text] [Related]
35. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma.
Doorakkers E; Lagergren J; Santoni G; Engstrand L; Brusselaers N
Helicobacter; 2020 Jun; 25(3):e12688. PubMed ID: 32175626
[TBL] [Abstract][Full Text] [Related]
37. Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort study.
Al-Kaabi A; Baranov NS; van der Post RS; Schoon EJ; Rosman C; van Laarhoven HWM; Verheij M; Verhoeven RHA; Siersema PD
Acta Oncol; 2022 May; 61(5):545-552. PubMed ID: 35112634
[TBL] [Abstract][Full Text] [Related]
38. Global Patterns and Trends in Gastric Cancer Incidence Rates (1988-2012) and Predictions to 2030.
Lin Y; Zheng Y; Wang HL; Wu J
Gastroenterology; 2021 Jul; 161(1):116-127.e8. PubMed ID: 33744306
[TBL] [Abstract][Full Text] [Related]
39. Tree nut, peanut, and peanut butter consumption and the risk of gastric and esophageal cancer subtypes: the Netherlands Cohort Study.
Nieuwenhuis L; van den Brandt PA
Gastric Cancer; 2018 Nov; 21(6):900-912. PubMed ID: 29594821
[TBL] [Abstract][Full Text] [Related]
40. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus.
Nguyen T; Thrift AP; Yu X; Duan Z; El-Serag HB
Am J Gastroenterol; 2017 Jul; 112(7):1049-1055. PubMed ID: 28244499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
